A state-backed market forecast says Hawaii could support a very large adult-use industry, yet lawmakers still keep legalization stuck between committee votes and caution flags.
Hawaii has arrived at an unusual place in the legalization debate. The state now has a more detailed evidence base than many early adopters had when they launched adult-use sales, including an attorney general framework in 2024, a fresh Department of Health-commissioned market analysis released in early 2026, and a real medical program that regulators can measure instead of imagine. Hawaii cannabis legalization still has not crossed the finish line. That disconnect is the story now: more modeling, more political familiarity, more market data, and no enacted adult-use law.
The 2024 cycle showed how close Hawaii cannabis legalization could get before budget math and institutional caution closed the door. Senate Bill 3335 passed the Senate on a 19-6 vote, moved through House committees, passed second reading in the House, and reached the Finance Committee, where Chair Kyle Yamashita declined to hear it. He said Maui fire recovery demanded fiscal attention and that the full cost of implementing adult-use legalization remained unknown. Hawaiʻi Public Radio called it the furthest a recreational marijuana bill had advanced in the state Legislature. That matters because the measure was not a loose concept draft. It followed a January 2024 attorney general report that laid out a full regulatory structure while also stating plainly that the department did not support legalization as a policy choice.
The 2025 session reinforced the same pattern with different choreography. House Bill 1246 won initial approval in two House committees, showing that Hawaii cannabis legalization still had organized support in one chamber. Then the bill was recommitted and effectively shelved for the year. Its Senate companion, Senate Bill 1613, died after being deleted from committee decision-making in late February. Momentum existed. Durability did not. For cannabis advocates and operators, that distinction is painful because it means policy can look alive in hearings and still collapse under procedure before the public ever gets a clean floor fight.
The new state-backed numbers explain why the issue keeps returning. According to the Department of Health-commissioned analysis, Hawaiʻi’s total current cannabis demand across medical, gray, and illicit channels sits between $16.5 million and $32 million a month. The legal medical market accounts for about $5.3 million of that monthly spending, and the report estimates roughly 29,780 past-month medical patients, about one-quarter of past-month cannabis consumers in the state. That is the central fact Hawaii cannabis legalization opponents and supporters both have to work around: demand already exists at scale, and most of it sits outside the taxed adult-use system lawmakers keep debating.
That is where the billion-dollar headline enters the chat, and it needs careful handling. The report itself does not declare a “$1 billion market” as its plain-language top line. It projects that by year five, total monthly demand under adult-use legalization could reach $59 million to $95 million, or $46 million to $90 million after adjusting for expected participation under a 15% total tax rate. Annualized, those ranges work out to roughly $708 million to $1.14 billion, or $552 million to $1.08 billion. So the billion-dollar claim is fair as an inference from the upper end of the modeling. It is less solid as a bumper sticker. Any honest coverage of Hawaii cannabis legalization should keep that distinction visible, because forecast and enacted market are two different animals.
Tourism adds real weight to the forecast, though it does not justify the laziest paradise-plus-pot fantasies. The report says tourists would contribute at least $11.5 million a month in additional demand under adult-use legalization, with domestic travelers driving most of that spending. At the same time, the same analysis found cannabis policy was not a decisive travel factor for most respondents in Japan or Canada. Most surveyed Japanese respondents said legalization would not affect their motivation to visit Hawaii, and most surveyed Canadian respondents said the same. Hawaii cannabis legalization, in other words, has a tourism upside without evidence for a miracle boom. It also lacks evidence for the doom narrative that legalization would suddenly scare off the visitor economy.
Where the report gets especially useful is in showing that Hawaii cannabis legalization would not be a zero-to-one buildout. Hawaii already has a statewide medical infrastructure. State law established eight dispensary licenses statewide, and as of Dec. 10, 2024, there were 38 operational licensed medical cannabis facilities: 13 production centers and 25 retail locations.
That gives lawmakers a baseline to judge expansion against. The adult-use report estimates Hawaii would need about 65 retail outlets in the first year to meet demand from adult-use consumers, medical patients and tourists. That is a major expansion. It is still an expansion from an existing system, not from bare dirt and a spreadsheet.
Cultivation capacity is where Hawaii cannabis legalization stops sounding abstract and starts sounding like an operations memo. The report estimates roughly 117,500 plants harvested and cured annually would be needed to serve adult-use, medical and tourism demand, and it warns regulators to build in flexibility so they can manage production and avoid surplus. That warning deserves more attention than it usually gets in political testimony. Washington state’s Joint Legislative Audit and Review Committee found in 2025 that businesses there produced two to three times more cannabis than retailers sold in 2023, a mismatch that contributed to challenging market conditions and exposed the limits of weak supply-and-demand oversight. Hawaii has the advantage of watching other states make expensive mistakes first. The state still has to decide whether it wants to learn from them.
That caution carries real public-health content, not just political cover. The Department of Health said the projected revenue from any adult-use system has to be weighed against prevention, treatment, education and safety costs. The attorney general’s office took a similar line in 2024, saying it did not support adult-use legalization even while providing lawmakers a framework designed to reduce harm if they moved ahead anyway. The Centers for Disease Control and Prevention says some people who use cannabis develop cannabis use disorder, with higher risk among people who start young and those who use more frequently. None of that settles the policy debate by itself. It does explain why Hawaii cannabis legalization keeps getting filtered through youth exposure, impaired driving, addiction and high-potency product concerns instead of through tax revenue alone.
Federal law still complicates everything. Even after the White House directed the Justice Department in December 2025 to complete the process of moving marijuana to Schedule III, that order did not legalize cannabis federally. Hawaii officials told lawmakers in February that the state still lacked a clear federal timeline and that rescheduling alone would not automatically solve the state program’s compliance problems.
That uncertainty helps explain the 2026 session’s strange middle ground. Broad adult-use legislation stalled again, while lawmakers entertained narrower concepts such as a low-dose bill with a 5-milligram THC cap and a separate conditional framework that would activate only after federal change or a constitutional amendment. Hawaii cannabis legalization remains politically alive. It remains procedurally fragile for the same reason it has for years: lawmakers keep asking for a cleaner federal backdrop, tighter cost estimates and stronger implementation assurances than supporters have yet delivered.
As of mid-March 2026, the broad picture has not changed. Hawaiʻi Public Radio reported last week that marijuana legalization is still among the measures stalled at the Legislature. That leaves Hawaii cannabis legalization in a familiar position, with an illicit market already serving plenty of demand, a medical system proving regulated access can function, and a state-commissioned report showing the adult-use opportunity could be very large under the right tax and licensing choices.
The best read on the moment is less dramatic than either side prefers. Hawaii is neither on the verge of instant legalization nor stuck in a pre-data era. It is in the awkward phase where the evidence base is becoming harder to ignore than the politics. For now, the numbers say the market is ready long before the Capitol is.
***
Trap Culture is the ultimate destination for cannabis enthusiasts who want to experience the best of Arizona’s cannabis culture. Whether you are looking for the hottest cannabis-friendly events, the latest news on cannabis legalization, trends in the industry and exclusive, limited-edition products from the top brands in the market, Trap Culture has you covered. Visit our website to learn more about our events, our blog, and our store. Follow us on social media to stay updated on the latest news and promotions. Join the Trap Culture family and experience the most immersive and engaging social cannabis events in Arizona.
Follow us on social media
